PERSPECTA

News from every angle

← Back to headlines

Pfizer reports positive data from a Phase 2 study for the atopic dermatitis antibody

9 Mar, 14:44 — 9 Mar, 14:44
PostShare

Sources

Showing 1 of 1 sources